Thyroid Gland Squamous Cell Carcinoma
4 clinical trials · Condition
◉ Watch Thyroid Gland Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer (NCT04171622) | M.D. Anderson Cancer Center | 2021-11-04 |
| Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer (NCT04675710) | M.D. Anderson Cancer Center | 2021-06-24 |
| Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer (NCT04759911) | M.D. Anderson Cancer Center | 2021-02-26 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
Track Thyroid Gland Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.